Rutaecarpine suppresses the proliferation and metastasis of colon cancer cells by regulating the STAT3 signaling
Shixin Chan, Rui Sun, Xucan Tu, Manyu Guo, Qianqian Yuan, Zhen Yu, Zhenglin Wang, Shaocheng Hong, Wei Han, Bingbing Zou, Zeng Li, Huabing Zhang, Wei Chen · Journal of Cancer · 2022
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2022
Abstract
Colorectal cancer (CRC) is a malignant disease that is a serious threat to human health.Rutaecarpine (RUT) is an important bioactive alkaloid of Evodia rutaecarpa.According to previous studies, RUT suppressed the proliferation of several human tumors.However, its role in colorectal tumorigenesis remained unknown.The aim of the present study was to determine the functions of RUT in CRC.Here, we have demonstrated that RUT inhibited the proliferation, migration and invasion of CRC cells in vitro.Further, RUT was found to induce the apoptosis of CRC cells.Mechanistically, RUT decreased the phosphorylation levels of NF-κB and STAT3.Moreover, treatment with RUT upregulated the expression of cleaved-Caspase3 and downregulated the expression of Bcl-2 in CRC.In addition, our findings suggested that RUT inhibited the growth and lung metastasis of CRC Cells in vivo.Based on immunofluorescence analysis, the expression of Ki67 was downregulated while that of cleaved-Caspase3 was upregulated in RUT-treated tumors compared with control-treated tumors.Taken together, our findings indicate that RUT can inhibit the proliferation and migration of CRC cells, and induce the apoptosis of CRC cells by inactivating NF-κB/STAT3 signaling.Our study highlights the potential clinical application of RUT for the treatment of CRC.
Open the resolved locator · 10.7150/jca.66177
Metadata licence: OpenAlex metadata (CC0)